• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙通道与钙通道药物:近期生化与生物物理研究发现

Calcium channels and calcium channel drugs: recent biochemical and biophysical findings.

作者信息

Glossmann H, Ferry D R, Goll A, Striessnig J, Zernig G

出版信息

Arzneimittelforschung. 1985;35(12A):1917-35.

PMID:2420337
Abstract

The biochemical and biophysical features of the voltage-dependent calcium channels, as discovered in vitro by means of radiolabelled drugs, are presented. The concept of distinct but reciprocally allosterically coupled drug receptor domains linked to calcium binding sites is explained. The evidence for the existence of isochannels (and isoreceptors) is reviewed and the voltage-dependence of 1,4-dihydropyridine binding and action is discussed. The structure of the channel is investigated by radiation-inactivation and by photoaffinity labelling. Low affinity binding sites for calcium channel drugs are shown to reside on the nucleoside carrier.

摘要

本文介绍了通过放射性标记药物在体外发现的电压依赖性钙通道的生化和生物物理特性。解释了与钙结合位点相连的不同但相互变构偶联的药物受体结构域的概念。综述了同型通道(和同型受体)存在的证据,并讨论了1,4 -二氢吡啶结合和作用的电压依赖性。通过辐射灭活和光亲和标记研究了通道的结构。结果表明,钙通道药物的低亲和力结合位点位于核苷载体上。

相似文献

1
Calcium channels and calcium channel drugs: recent biochemical and biophysical findings.钙通道与钙通道药物:近期生化与生物物理研究发现
Arzneimittelforschung. 1985;35(12A):1917-35.
2
Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.钙通道的分子药理学:关于亚型、多个药物受体位点、通道亚基的证据以及放射性碘化的1,4 - 二氢吡啶钙通道标记物[125I]碘尼地平的研发。
J Cardiovasc Pharmacol. 1984;6 Suppl 4:S608-21.
3
The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.1,4-二氢吡啶受体:钙通道的一种调节成分。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S949-55.
4
Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.完整心肌细胞中钙通道的研究:二氢吡啶对映体的电压依赖性效应及协同相互作用
Mol Pharmacol. 1986 Dec;30(6):571-84.
5
Calcium channels: basic properties as revealed by radioligand binding studies.钙通道:放射性配体结合研究揭示的基本特性
J Cardiovasc Pharmacol. 1985;7 Suppl 6:S20-30.
6
A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.二氢吡啶对心肌膜的结合作用与电生理效应的比较。
Mol Pharmacol. 1987 Mar;31(3):221-31.
7
The voltage-dependent effect of 1,4-dihydropyridine enantiomers on Ca channels in cardiac cells.1,4 - 二氢吡啶对映体对心肌细胞钙通道的电压依赖性效应。
Jpn Heart J. 1986 Nov;27 Suppl 1:57-63.
8
Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.心脏和血管平滑肌中的兴奋-收缩偶联:钙内流阻滞剂的影响
Circulation. 1987 Jun;75(6 Pt 2):V3-14.
9
Calcium-channel drugs: structure-function relationships and selectivity of action.
J Cardiovasc Pharmacol. 1991;18 Suppl 10:S1-6.
10
[Biochemical and pharmacologic properties of the Ca2+ channel of skeletal muscle: appearance during myogenesis and the relation between its structure and function].
J Physiol (Paris). 1986;81(3):177-84.

引用本文的文献

1
4-Pyridinio-1,4-Dihydropyridines as Calcium Ion Transport Modulators: Antagonist, Agonist, and Dual Action.4-吡啶基-1,4-二氢吡啶类化合物作为钙离子转运调节剂:拮抗剂、激动剂和双重作用。
Oxid Med Cell Longev. 2020 Mar 27;2020:2075815. doi: 10.1155/2020/2075815. eCollection 2020.
2
Structural basis for inhibition of a voltage-gated Ca channel by Ca antagonist drugs.钙拮抗剂药物对电压门控钙通道的抑制作用的结构基础。
Nature. 2016 Sep 1;537(7618):117-121. doi: 10.1038/nature19102. Epub 2016 Aug 24.
3
Poster communications.壁报交流
Br J Pharmacol. 1993 Jul;109(Suppl):67P-142P.
4
A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.一项针对抗二氢吡啶(DHP)蠕虫的基因筛选揭示了哺乳动物钙通道DHP阻断所需的新残基。
PLoS Genet. 2008 May 9;4(5):e1000067. doi: 10.1371/journal.pgen.1000067.
5
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.米贝拉地尔与电压门控钙通道和钠通道的高亲和力相互作用。
Br J Pharmacol. 2000 Jun;130(3):669-77. doi: 10.1038/sj.bjp.0703352.
6
Molecular basis of drug interaction with L-type Ca2+ channels.药物与L型钙离子通道相互作用的分子基础。
J Bioenerg Biomembr. 1998 Aug;30(4):319-34. doi: 10.1023/a:1021933504909.
7
Determination of (+)- and (-)-nicardipine concentrations in human serum and their correlation with the antihypertensive effect after oral administration of racemic nicardipine.口服消旋尼卡地平后人体血清中(+)-和(-)-尼卡地平浓度的测定及其与降压效果的相关性。
Eur J Clin Pharmacol. 1995;48(5):345-9. doi: 10.1007/BF00194949.
8
Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.1,4 - 二氢吡啶类药物伊拉地平与拉西地平与平滑肌钙通道相互作用的放射性配体及功能评估
Br J Pharmacol. 1993 May;109(1):100-6. doi: 10.1111/j.1476-5381.1993.tb13537.x.
9
Inhibitory action of SR33557 on L-type calcium current in single ventricular myocytes of rat.SR33557对大鼠单个心室肌细胞L型钙电流的抑制作用。
Br J Pharmacol. 1995 Jan;114(2):468-74. doi: 10.1111/j.1476-5381.1995.tb13250.x.
10
Quinidine-induced potentiation of cardiovascular effects of nitrendipine: functional aspects and possible molecular mechanisms.
Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):636-43. doi: 10.1007/BF00170164.